LPL Financial
ALT icon

LPL Financial’s Altimmune ALT Stock Holding History

LPL Financial’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$371K Buy
121,952
+18,196
+18% +$54.3K ﹤0.01% 5284
2026
Q1 		$320K Buy
103,756
+55,130
+113% +$234K ﹤0.01% 5147
2025
Q4 		$176K Sell
48,626
-12,898
-21% -$56.2K ﹤0.01% 5480
2025
Q3 		$232K Sell
61,524
-13,969
-19% -$53.9K ﹤0.01% 5246
2025
Q2 		$292K Buy
75,493
+8,912
+13% +$48.2K ﹤0.01% 4793
2025
Q1 		$333K Buy
66,581
+8,408
+14% +$53.3K ﹤0.01% 4501
2024
Q4 		$419K Buy
58,173
+7,693
+15% +$58.8K ﹤0.01% 4244
2024
Q3 		$310K Sell
50,480
-1,182
-2% -$8.01K ﹤0.01% 4406
2024
Q2 		$344K Sell
51,662
-1,767
-3% -$13K ﹤0.01% 4166
2024
Q1 		$544K Buy
53,429
+18,987
+55% +$193K ﹤0.01% 3706
2023
Q4 		$387K Buy
+34,442
New +$144K ﹤0.01% 3876
2016
Q2 		– Sell
-33
Closed -$21K – 2634
2016
Q1 		$21K Buy
+33
New +$16.9K ﹤0.01% 3056

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LPL Financial's ALT Position: Q2 2026 in Review

LPL Financial increased its Altimmune (ALT) stake by 18% in Q2 2026, buying an estimated $54.3K and bringing the position to 121,952 shares worth $371K. The position accounts for ﹤0.01% of the portfolio, ranked #5284.

LPL Financial first reported a position in ALT in Q1 2016 and has held it in 12 quarters since. The position peaked at $544K in Q1 2024. 211 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • LPL Financial held 121,952 shares of Altimmune worth $371K as of Q2 2026.
  • LPL Financial bought 18,196 Altimmune shares in Q2 2026, an estimated $54.3K.
  • Altimmune made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5284 holding.
  • LPL Financial first reported a position in Altimmune in Q1 2016 and has held it in 12 quarters since.
  • LPL Financial's Altimmune position peaked at $544K in Q1 2024.
  • 211 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.